Ask Warren

JW Lifescience

234080 · KOSPI · ₩234080 · JW생명과학

₩10,440▲ ₩20 (0.19%)End-of-day · Oct 27, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩63B₩64B₩64B₩63B₩62B₩69B₩55B₩58B
Cost of sales₩45B₩45B₩46B₩46B₩43B₩51B₩40B₩44B
Gross profit₩18B₩19B₩18B₩17B₩19B₩18B₩15B₩14B
Operating income₩9.3B₩9.3B₩7.6B₩7.1B₩9.4B₩9.2B₩9.6B₩9.3B
Net income₩1.3B₩6.7B₩24B−₩6.3B₩5.1B₩6.1B₩37B₩105M
Net income to shareholders₩8B₩6.7B₩24B−₩6.3B₩5.1B₩6.1B₩37B₩105M

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩306B₩314B₩318B₩310B₩313B₩325B₩325B₩262B
Current assets₩82B₩88B₩88B₩100B₩102B₩110B₩106B₩124B
Cash and equivalents₩9B₩8.9B₩8.4B₩6.9B₩8.6B₩7.4B₩7.5B₩49B
Total liabilities₩79B₩95B₩98B₩95B₩103B₩126B₩125B₩92B
Current liabilities₩65B₩81B₩84B₩83B₩90B₩81B₩80B₩59B
Borrowings₩31B₩40B₩49B₩30B₩37B₩40B₩40B₩29B
Total equity₩227B₩219B₩221B₩215B₩210B₩199B₩200B₩170B
Shareholders' equity₩227B₩219B₩221B₩215B₩210B₩199B₩200B₩170B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩17B₩14B₩5.1B₩11B₩17B₩7.3B₩5.7B₩27B
Capital spending₩1.3B₩3.3B₩3.5B₩4.3B₩1.7B₩3.1B₩4.5B₩2.8B
Free cash flow₩16B₩11B₩1.6B₩7B₩15B₩4.2B₩1.2B₩24B
Dividends paid₩0₩8.5B₩0₩0₩7.7B₩0₩0₩0

Consolidated where available. Amounts in won.

Also known as: JW Lifescience / JW생명과학 / 234080 / KRX:234080

Source: KRX statistical information